Clinical Trial Update: A Study of the Safety and Effectiveness of Galantamine Hydrobromide in Patients With Alzheimer's Disease

View source ↗

Summary

This document reports the completion of a clinical trial evaluating the safety and effectiveness of galantamine hydrobromide in patients with Alzheimer's diseas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• GALANTAMINE HYDROBROMIDE (GALANTAMINE HYDROBROMIDE)

Snippet

Sponsor: Janssen Cilag Pharmaceutica S.A.C.I., Greece | Conditions: Alzheimer Disease | Status: COMPLETED